Silence Therapeutics PLC Sustainability Reports
Silence Therapeutics PLC is a clinical-stage biotechnology company that discovers and develops novel short interfering ribonucleic acid (siRNA) therapeutics to precisely target and silence disease-causing genes.
Sector: Manufacturing
Country: United Kingdom
Exchange: OTC Markets
LEI: 213800SSURRJBX85SQ91
FIGI: BBG001SCXRG7
7 reports from 2012 to 2025